Cargando…
TRAIL-based gene delivery and therapeutic strategies
TRAIL (tumor necrosis factor-related apoptosis-inducing ligand), also known as APO2L, belongs to the tumor necrosis factor family. By binding to the death receptor 4 (DR4) or DR5, TRAIL induces apoptosis of tumor cells without causing side toxicity in normal tissues. In recent years TRAIL-based ther...
Autores principales: | Zhong, Hui-hai, Wang, Hui-yuan, Li, Jian, Huang, Yong-zhuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889127/ https://www.ncbi.nlm.nih.gov/pubmed/31444476 http://dx.doi.org/10.1038/s41401-019-0287-8 |
Ejemplares similares
-
Publisher Correction: ‘TRAIL-based gene delivery and therapeutic strategies’ and ‘Overview of recent advances in liposomal nanoparticle-based cancer immunotherapy’
por: Zhong, Hui-ha, et al.
Publicado: (2020) -
Role of nanotechnology and gene delivery systems in TRAIL-based therapies
por: Naoum, George E, et al.
Publicado: (2016) -
Therapeutic targeting of TRAIL death receptors
por: Di Cristofano, Francesca, et al.
Publicado: (2023) -
MSC based gene delivery methods and strategies improve the therapeutic efficacy of neurological diseases
por: Zhou, Heng, et al.
Publicado: (2022) -
Regulation of the human TRAIL gene
por: Allen, Joshua E., et al.
Publicado: (2012)